Policy Program

Overview

At Stanford Biodesign, we teach a step-by-step approach to innovation, which at its core is about solving problems in healthcare in order to improve lives everywhere.

We introduced the concept of innovation in medicine as a disciplined process that can be taught, learned, practiced, and perfected. Innovation in health policy is the next step in our mission to provide healthcare providers and patients with timely access to proven new health innovations.

Our Vision

We are committed to accelerating the translation of research into health policy solutions, and see a future where governing bodies collaborate with innovators to improve healthcare while securing a vibrant innovation ecosystem.

Using data-driven insights to drive decision-making, policymakers and innovators can collaborate to improve patient outcomes, lower costs to the healthcare system, and boost the patient and healthcare provider experience.

Our Approach

Our Innovation Policy Program supports our vision with:

Policy Research – Delivering timely, relevant, and balanced research to assist policymakers in making data-driven decisions as they set new policies governing promising health technologies. Research outputs include peer-reviewed publications, editorials, commentary, presentations, and webinars.

Policy Education – Educating the next generation of policy leaders and innovators on the impact that policy can have in advancing or hindering health technology innovation. Learn more about our first educational offering – the Stanford Biodesign Policy Fellowship.

Community Engagement – Convening leaders across the health policy and health technology ecosystems to catalyze new relationships and ideas that support greater collaboration. See below for examples of past events.

Get Involved

To learn more about how you can contribute to our vision or to be added to our mailing list, contact us.

Research & Publications

The Need for Accelerated Medicare Coverage of Innovative Technologies: Impact on Patient Access and the Innovation Ecosystem, January 25, 2022, Health Management, Policy and Innovation.

Recent Events

Webinar: The Need for Transitional Coverage for Emerging Technologies
The Duke-Margolis Center for Health Policy and the Stanford Byers Center for Biodesign co-hosted a public webinar on March 28, 2022, that focused on the need for a well-designed coverage program that could accelerate patient access to critical new medical innovations. The webinar highlighted stakeholder perspectives, including those of CMS, innovators, and policymakers.
Read the Meeting Summary
View the Presentation Slides
Watch the Recording

Webinar: CPT Codes and Innovation
One of the keys to a successful invention is understanding how a new device or procedure fits into the current procedural code (CPT) landscape. We organized this American Medical Association webinar in September 2021 to help physician innovators understand how the CPT process works, how to engage with the CPT Editorial Panel, and when to apply for a new code. Co-sponsored by Fogarty Innovation with MDMA, Wilson Sonsini Goodrich & Rosati, Silicon Valley Bank, MedTech Strategist, and AdvaMed.
View the Presentation Slides
Watch the Recording

Prior Publications

A Comprehensive Analysis of the FDA 510(k) Process, 2011.

FDA Impact on US Medical Technology Innovation, 2010.

Stanford Researchers Publish Comprehensive Model for Medical Device Development, 2009.

 

Why Stanford Biodesign?

Our Policy Program taps into the knowledge and expertise of world-class faculty and researchers across Stanford University, including:

  • Stanford Department of Health Policy
  • Stanford School of Medicine
  • Stanford Law School
  • Clinical Excellence Research Center
  • Freeman Spogli Institute for International Studies
  • Innovative Medicines Accelerator
  • Stanford Institute for Economic Policy Research
  • Stanford Engineering
  • Stanford Graduate School of Business